Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01386580
Title An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors to-BBB technologies B.V.
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | BEL

Facility Status City State Zip Country Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Universitair Ziekenhuis Antwerpen Antwerp B-2650 Belgium Details
Jules Bordet Institute Brussels B-1000 Belgium Details
Institut Curie Paris Paris Cedex 05 75248 France Details
Institut Gustave Roussy Villejuif Val de Marne 94805 France Details
Antoni van Leeuwenhoek Ziekenhuis Amsterdam 1066 CX Netherlands Details
Vrije Universiteit medisch centrum (Vumc) Amsterdam 1081 HV Netherlands Details
Leids Universitair Medisch Centrum (LUMC) Leiden 2333 CA Netherlands Details
Maastricht Universitair Medisch Centrum Maastricht 6229 HX Netherlands Details
Erasmus MC Rotterdam 3075 EA Netherlands Details
*Shaded cells indicate that there was no data available from for the field